Zhu Zeng Tao Wang Junjun He Yuehong Wang
10.3389/fonc.2022.1010084
Front Oncol
2022 Oct 31;12:1010084.
alk fusion egfr-tki resistance alectinib lung cancer non-reciprocal/reciprocal alk
CC BY
https://pubmed.ncbi.nlm.nih.gov/36387181/
Case Reports
PMC9660230
36387181
ALK-R3HDM1 and EML4-ALK fusion as a mechanism of acquired resistance to gefitinib: A case report and literature review
2022